Refine
Has Fulltext
- yes (27)
Is part of the Bibliography
- yes (27)
Year of publication
Document Type
- Journal article (27)
Language
- English (27) (remove)
Keywords
- ADHD (5)
- depression (4)
- bipolar disorder (3)
- mental health (3)
- pregnancy (3)
- BDNF (2)
- Bipolar disorder (2)
- antidepressant (2)
- anxiety (2)
- attention (2)
- hyperactivity (2)
- impulsivity (2)
- lactation (2)
- mental disorders (2)
- peripartum (2)
- polygenic risk score (2)
- systematic review (2)
- ADHD patients (1)
- Abelson helper integration-1 (AHI1) (1)
- Adult (1)
- Aggression (1)
- Alzheimers disease (1)
- Antisocial behavior (1)
- Association (1)
- Biomarke (1)
- C-reactive protein (1)
- COVID-19 (1)
- Conduct disorder (1)
- Covid-19 (1)
- Cytokines (1)
- Deficit/hyperactivity disorder (1)
- Depression (1)
- Diagnostic approach (1)
- EBM (1)
- Fibromyalgia syndrome (1)
- GHQ-28 (1)
- GRN (1)
- GWAS (1)
- Gene (1)
- Genotype (1)
- Inflammatio (1)
- Large multicenter ADHD (1)
- Maintenance treatment (1)
- Mania (1)
- Monopolar depression (1)
- NSSI (1)
- Nesplora Aquarium (1)
- Opioid receptor (1)
- PARK2 (1)
- Polarity index (1)
- Predominant polarity (1)
- Qb-Test (1)
- Rating scale (1)
- Schizophrenie (1)
- Skin biopsy (1)
- Susceptibility loci (1)
- UPPS (1)
- accidents (1)
- adolescence (1)
- adult attention deficit/hyperactivity disorder (adult ADHD) (1)
- age (1)
- antidepressants (1)
- anxious depression (1)
- association (1)
- astrocytes (1)
- attention deficit hyperactivity disorder (1)
- breast cancer (1)
- ceramides (1)
- child development (1)
- clinical practice guideline (1)
- cognitive deficits (1)
- cohort studies (1)
- continuous performance test (1)
- cortical activation (1)
- cross-sectional studies (1)
- cross-sectional study (1)
- dementia (1)
- depressive disorder (1)
- disease modelling (1)
- early recognition (1)
- emotion regulation (1)
- endocannabinoids (1)
- fNIRS (1)
- families (1)
- family caregivers (1)
- fibromyalgia syndrome (1)
- frontotemporal lobar degeneration (1)
- gene (1)
- gene ADGRL3 (1)
- geneexpression (1)
- genetic phenotypes (1)
- genome-wide association (1)
- glia (1)
- hiPSC (1)
- iPSCs (1)
- illness (1)
- incidence (1)
- induced pluripotent stem cells (1)
- informal caregiving (1)
- linkage (1)
- lithium (1)
- longitudinal studies (1)
- major depression (1)
- mapping susceptibility genes (1)
- maternal (1)
- mechanismofaction (1)
- mental illness (1)
- mitochondria (1)
- monoamine transporters (1)
- mood disorders (1)
- morality (1)
- mutation (1)
- near-infrared spectroscopy (1)
- neuropsychology (1)
- nitricoxidesynthase (1)
- non-suicidal self-injury (1)
- observer agreement (1)
- onset (1)
- pain (1)
- paternal (1)
- people (1)
- pharmacotherapy (1)
- physical health (1)
- population-based studies (1)
- postnatal depression (1)
- prefrontal cortex (1)
- prevalence (1)
- prevention (1)
- prophylactic lithium (1)
- psychological distress (1)
- psychosocial stress (1)
- psychotropic medication (1)
- psychotropic medications (1)
- reliability (1)
- remitted/acute phase (1)
- risk SNP rs1397547 (1)
- risk genes (1)
- self-employed (1)
- small business (1)
- stress (1)
- substance abuse disorder (1)
- tandem mass spectrometry (1)
- therapy response (1)
- universal prevention (1)
- venturesomeness (1)
- verbal n-back (1)
Institute
- Klinik und Poliklinik für Psychiatrie, Psychosomatik und Psychotherapie (25)
- Frauenklinik und Poliklinik (2)
- Institut für Klinische Epidemiologie und Biometrie (2)
- Klinik und Poliklinik für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (2)
- Lehrstuhl für Molekulare Psychiatrie (2)
- Neurologische Klinik und Poliklinik (2)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (1)
- Institut für Psychologie (1)
Sonstige beteiligte Institutionen
There is still limited knowledge about alterations of blood concentrations of psychotropic drugs during pregnancy, the transfer of psychotropic drugs into breastmilk and the effects on exposed children. We investigated changes in concentrations of psychopharmacological medication during pregnancy and lactation in serum and breastmilk at different time points in a naturalistic sample of 60 mothers and observed the development of the exposed children in the first 12 months. We found a decrease in serum concentrations from the first to the second trimester of amitriptyline, duloxetine, escitalopram, quetiapine and sertraline. Citalopram stayed rather stable during pregnancy, sertraline levels interestingly increased again from the second to the third trimester. High concentration-by-dose ratios in breastmilk were found for venlafaxine as well as lamotrigine, low for quetiapine and clomipramine. Similarly, clomipramine and quetiapine showed low milk/serum–penetration ratios. Regarding the birth outcome measures in children, we found no significant differences between in utero exposed compared to nonexposed newborns. There were no significant differences in the development in the first 12 months. Psychotropic medication in the peripartum needs a balancing of risks and benefits and a continuous therapeutic drug monitoring can be a guidance for clinicians to monitor drug alteration patterns, which are likely to occur due to physiological pregnancy-associated changes in pharmacokinetics. Accordingly, therapeutic drug monitoring can optimize a medication in pregnancy and lactation with the lowest effective dose.